BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Triponez F, Sadowski SM, Pattou F, Cardot-Bauters C, Mirallié E, Le Bras M, Sebag F, Niccoli P, Deguelte S, Cadiot G, Poncet G, Lifante JC, Borson-Chazot F, Chaffanjon P, Chabre O, Menegaux F, Baudin E, Ruszniewski P, Du Boullay H, Goudet P. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines. Ann Surg 2018;268:158-64. [PMID: 28263205 DOI: 10.1097/SLA.0000000000002191] [Cited by in Crossref: 56] [Cited by in F6Publishing: 16] [Article Influence: 18.7] [Reference Citation Analysis]
Number Citing Articles
1 Febrero B, Ríos A, Cayuela V, Sánchez-bueno F, Rodríguez JM. Síndrome de neoplasia endocrina múltiple tipo 1 y tumores neuroendocrinos pancreáticos. Abordaje laparoscópico. Cirugía Española 2022. [DOI: 10.1016/j.ciresp.2022.01.006] [Reference Citation Analysis]
2 Christou N, Mathonnet M, Gaujoux S, Cadiot G, Deguelte S, Kraimps JL, Lifante JC, Menegaux F, Mirallié E, Muscari F, Carnaille B, Pattou F, Sauvanet A, Goudet P. One-Year Postoperative Mortality in MEN1 Patients Operated on Gastric and Duodenopancreatic Neuroendocrine Tumors: An AFCE and GTE Cohort Study. World J Surg 2019;43:2856-64. [PMID: 31384998 DOI: 10.1007/s00268-019-05107-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
3 van Beek DJ, Nell S, Pieterman CRC, de Herder WW, van de Ven AC, Dekkers OM, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Borel Rinkes IHM, Vriens MR, Valk GD. Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG). J Surg Oncol 2019;120:966-75. [PMID: 31401809 DOI: 10.1002/jso.25667] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Kamilaris CDC, Stratakis CA. Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis.Front Endocrinol (Lausanne). 2019;10:339. [PMID: 31263451 DOI: 10.3389/fendo.2019.00339] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 13.7] [Reference Citation Analysis]
5 van Beek DJ, Nell S, Verkooijen HM, Borel Rinkes IHM, Valk GD, Vriens MR; (on behalf of the DutchMEN study group)., International MEN1 Insulinoma Study Group. Surgery for multiple endocrine neoplasia type 1-related insulinoma: long-term outcomes in a large international cohort. Br J Surg 2020;107:1489-99. [PMID: 32352164 DOI: 10.1002/bjs.11632] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Han X, Lou W. Concomitant pancreatic neuroendocrine tumors in hereditary tumor syndromes: who, when and how to operate? Journal of Pancreatology 2019;2:48-53. [DOI: 10.1097/jp9.0000000000000016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
7 de Ponthaud C, Menegaux F, Gaujoux S. Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know. Cancers (Basel) 2021;13:5969. [PMID: 34885079 DOI: 10.3390/cancers13235969] [Reference Citation Analysis]
8 Selberherr A, Koperek O, Riss P, Scheuba C, Niederle MB, Kaderli R, Perren A, Niederle B. Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1. Orphanet J Rare Dis 2019;14:54. [PMID: 30795813 DOI: 10.1186/s13023-019-1034-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Santucci N, Gaujoux S, Binquet C, Reichling C, Lifante JC, Carnaille B, Pattou F, Mirallié E, Facy O, Mathonnet M, Goudet P. Pancreatoduodenectomy for Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: An AFCE (Association Francophone de Chirurgie Endocrinienne) and GTE (Groupe d'étude des Tumeurs Endocrines) Study. World J Surg 2021;45:1794-802. [PMID: 33649917 DOI: 10.1007/s00268-021-06005-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 van Treijen MJC, van Beek DJ, van Leeuwaarde RS, Vriens MR, Valk GD. Diagnosing Nonfunctional Pancreatic NETs in MEN1: The Evidence Base. J Endocr Soc. 2018;2:1067-1088. [PMID: 30202829 DOI: 10.1210/js.2018-00087] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
11 Kemm MH, Manly CD, Hoang TD, Mai VQ, Shakir MKM. Octreotide Use in a Patient with MEN-1 Syndrome and Multifocal Pancreatic Neuroendocrine Tumors: A Case Report and Review of the Literature. Case Rep Gastrointest Med. 2019;2019:9462942. [PMID: 31183223 DOI: 10.1155/2019/9462942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 van Beek DJ, Nell S, Vorselaars WMCM, Bonsing BA, van Eijck CHJ, van Goor H, Nieveen van Dijkum EJ, Dejong CHC, Valk GD, Borel Rinkes IHM, Vriens MR; DutchMEN Study Group (DMSG). Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort. Ann Surg Oncol 2021;28:4387-99. [PMID: 33521900 DOI: 10.1245/s10434-020-09496-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wu W, Chen J, Bai C, Chi Y, Du Y, Feng S, Huo L, Jiang Y, Li J, Lou W, Luo J, Shao C, Shen L, Wang F, Wang L, Wang O, Wang Y, Wu H, Xing X, Xu J, Xue H, Xue L, Yang Y, Yu X, Yuan C, Zhao H, Zhu X, Zhao Y. The Chinese guidelines for the diagnosis and treatment of pancreatic neuroendocrine neoplasms (2020). Journal of Pancreatology 2021;4:1-17. [DOI: 10.1097/jp9.0000000000000064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Mele C, Mencarelli M, Caputo M, Mai S, Pagano L, Aimaretti G, Scacchi M, Falchetti A, Marzullo P. Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations. Front Endocrinol (Lausanne) 2020;11:591501. [PMID: 33312161 DOI: 10.3389/fendo.2020.591501] [Reference Citation Analysis]
15 Wu W, Jin G, Li H, Miao Y, Wang C, Liang T, Ou J, Zhao Y, Yuan C, Li Y, Lou W, Wu Z, Qin R, Wang H, Hao J, Yu X, Huang H, Tan G, Liu X, Xu K, Wang L, Yang Y, Hao C, Wang W, Guo K, Wei J, Wang Y, Peng C, Wang X, Cai S, Jiang J, Wu X, Yu X, Li F, Zhao Y. The current surgical treatment of pancreatic neuroendocrine neoplasms in China: a national wide cross-sectional study. Journal of Pancreatology 2019;2:35-42. [DOI: 10.1097/jp9.0000000000000019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
16 Frey S, Mirallié E, Le Bras M, Regenet N. What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review. Cancers (Basel) 2021;13:5954. [PMID: 34885063 DOI: 10.3390/cancers13235954] [Reference Citation Analysis]
17 Souche R, Hobeika C, Hain E, Gaujoux S. Surgical Management of Neuroendocrine Tumours of the Pancreas. J Clin Med. 2020;9. [PMID: 32947997 DOI: 10.3390/jcm9092993] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Khatami F, Tavangar SM. Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives. Biomark Insights 2018;13:1177271918785129. [PMID: 30013307 DOI: 10.1177/1177271918785129] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
19 Soczomski P, Jurecka-Lubieniecka B, Krzywon A, Cortez AJ, Zgliczynski S, Rogozik N, Oczko-Wojciechowska M, Pawlaczek A, Bednarczuk T, Jarzab B. A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype-Phenotype Correlations. Front Endocrinol (Lausanne) 2021;12:681013. [PMID: 34122352 DOI: 10.3389/fendo.2021.681013] [Reference Citation Analysis]
20 Marini F, Giusti F, Tonelli F, Brandi ML. Multiple endocrine neoplasia type 1: a review of current diagnostic and treatment approaches. Expert Opinion on Orphan Drugs 2020;8:367-77. [DOI: 10.1080/21678707.2020.1811086] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Marx SJ. Recent Topics Around Multiple Endocrine Neoplasia Type 1. J Clin Endocrinol Metab. 2018;103:1296-1301. [PMID: 29897580 DOI: 10.1210/jc.2017-02340] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
22 Al-Salameh A, Cadiot G, Calender A, Goudet P, Chanson P. Clinical aspects of multiple endocrine neoplasia type 1. Nat Rev Endocrinol 2021;17:207-24. [PMID: 33564173 DOI: 10.1038/s41574-021-00468-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
23 Cloyd JM, Poultsides GA. The Landmark Series: Pancreatic Neuroendocrine Tumors. Ann Surg Oncol 2021;28:1039-49. [PMID: 32948965 DOI: 10.1245/s10434-020-09133-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]